Showing results (91-100 of 539) with videos related to
Sort By:
Pageof 54
Frontiers in Oncology|May 20, 2020
Coronavirus: Older Persons With Cancer in Italy in the COVID-19 PandemicLucia Fratino, Giuseppe Procopio, Massimo Di Maio, et al.Expert Review of Anticancer Therapy|August 23, 2016
Systemic treatment of hepatocellular carcinoma: why so many failures in the development of new drugs?Maria Pia Brizzi, Daniele Pignataro, Marco Tampellini, et al.European Journal of Cancer Care|December 23, 2016
Patients' perception of chemotherapy side effects: Expectations, doctor-patient communication and impact on quality of life - An Italian surveyDomenica Lorusso, Emilio Bria, Anna Costantini, et al.Clinical Genitourinary Cancer|July 27, 2023
Poly (ADP-Ribose) Polymerase Inhibitors in Patients With Urothelial CancerTeresa Gamba, Jessica Paparo, Olimpia Panepinto, et al.Clinical Lung Cancer|June 24, 2014
management of nonhematologic toxicities associated with different EGFR-TKIs in advanced NSCLC: a comparison analysisAntonio Passaro, Massimo Di Maio, Ester Del Signore, et al.Tumori|August 16, 2023
Italian oncologists and vaccinations against infectious diseases: Results of a survey of the Italian Association of Medical OncologyAngioletta Lasagna, Antonella Brunello, Nicola Silvestris, et al.Immunotherapy|November 22, 2021
Can we identify a preferred first-line strategy for sarcomatoid renal cell carcinoma? A network meta-analysisSebastiano Buti, Melissa Bersanelli, Giulia Mazzaschi, et al.Anticancer Research|May 27, 2026
Basaloid Urothelial Carcinoma Presenting With Paraneoplastic Hypercalcemia and Leukocytosis: A Case Report and Literature ReviewPaola Sabbadini, Eleonora Paganoni, Letizia Galeasso, et al.Lung Cancer (Amsterdam, Netherlands)|August 22, 2013
Economic analysis of a randomized phase III trial of gemcitabine plus vinorelbine compared with cisplatin plus vinorelbine or cisplatin plus gemcitabine for advanced non-small-cell lung cancer (Italian GEMVIN3/NCIC CTG BR14 trial)M Neil Reaume, Natasha B Leighl, Nicole Mittmann, et al.Pageof 54